Clinical Implications of Cardiac Ryanodine Receptor/Calcium Release Channel Mutations Linked to Sudden Cardiac Death

作者: Andrew R. Marks

DOI: 10.1161/01.CIR.0000021746.82888.83

关键词: RYR1Muscle contractionSkeletal muscleEndocrinologyBiologyCatecholaminergic polymorphic ventricular tachycardiaRyanodine receptor 2Cardiac muscleInternal medicineRyanodine receptorSudden cardiac death

摘要: The cardiac ryanodine receptor (RyR2) is the major calcium (Ca2+) release channel on sarcoplasmic reticulum (SR) in cardiomyocytes. During excitation-contraction, coupling intracellular Ca2+ stored SR released via RyR2 to activate muscle contraction. In heart, excitation-contraction activated by influx L-type that activates RyR2, a process referred as Ca2+-induced release.1,2⇓ and its homologue, skeletal RyR1, are macromolecular complexes include four ≈565-kDa RyR1 or FKBP12 FKBP12.6 (12-kDa peptidyl-prolyl isomerases required for normal gating of channels), well cAMP-dependent kinase (PKA), phosphatases, their targeting proteins.3–5⇓⇓ One key role signaling complex modulate function response activation sympathetic nervous system (ie, classic “fight-or-flight” stress response).5,6⇓ See p 69 In past year, three groups have independently discovered at least 21 mutations (Figure) linked stress-induced sudden death.7–9⇓⇓ To date, been associated with 2 forms death (SCD): (1) catecholaminergic polymorphic ventricular tachycardia (CPVT) familial (FPVT), (2) arrhythmogenic right dysplasia type (ARVD2). Exercise-induced SCD-linked mutations. Locations SCD human compared MH/CCD regions known regulatory domains channel. Eleven reported mutations7–9⇓⇓ cluster homologous regions.30,31⇓ Common polymorphisms indicated italics. location 3 leucine/isoleucine zippers (LZ) target PP1, PP2A, PKA shown,5,6⇓ binding region,32 CaM site.33 …

参考文章(33)
John D Fisher, Dennis Krikler, Katherine A Hallidie-Smith, Familial polymorphic ventricular arrhythmias Journal of the American College of Cardiology. ,vol. 34, pp. 2015- 2022 ,(1999) , 10.1016/S0735-1097(99)00438-6
Heikki Swan, Kirsi Piippo, Matti Viitasalo, Päivi Heikkilä, Timo Paavonen, Katariina Kainulainen, Juha Kere, Pekka Keto, Kimmo Kontula, Lauri Toivonen, Arrhythmic disorder mapped to chromosome 1q42–q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts Journal of the American College of Cardiology. ,vol. 34, pp. 2035- 2042 ,(1999) , 10.1016/S0735-1097(99)00461-1
Antoine Leenhardt, Vincent Lucet, Isabelle Denjoy, Francis Grau, Dien Do Ngoc, Philippe Coumel, Catecholaminergic Polymorphic Ventricular Tachycardia in Children A 7-Year Follow-up of 21 Patients Circulation. ,vol. 91, pp. 1512- 1519 ,(1995) , 10.1161/01.CIR.91.5.1512
A. Rampazzo, A. Nava, P. Erne, M. Eberhard, E. Vian, P. Slomp, N. Tiso, G. Thiene, G. A. Danieli, A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42–q43 Human Molecular Genetics. ,vol. 4, pp. 2151- 2154 ,(1995) , 10.1093/HMG/4.11.2151
G. Avila, J. J. O'Brien, R. T. Dirksen, Excitation–contraction uncoupling by a human central core disease mutation in the ryanodine receptor Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 4215- 4220 ,(2001) , 10.1073/PNAS.071048198
Marta Gaburjakova, Jana Gaburjakova, Steven Reiken, Fannie Huang, Steven O. Marx, Nora Rosemblit, Andrew R. Marks, FKBP12 binding modulates ryanodine receptor channel gating. Journal of Biological Chemistry. ,vol. 276, pp. 16931- 16935 ,(2001) , 10.1074/JBC.M100856200
M Nabauer, G Callewaert, L Cleemann, M Morad, Regulation of calcium release is gated by calcium current, not gating charge, in cardiac myocytes Science. ,vol. 244, pp. 800- 803 ,(1989) , 10.1126/SCIENCE.2543067
Tommie V. McCarthy, Kathleen A. Quane, Patrick J. Lynch, Ryanodine receptor mutations in malignant hyperthermia and central core disease. Human Mutation. ,vol. 15, pp. 410- 417 ,(2000) , 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D